Photo Rounds

Painful lumps in the axilla

Author and Disclosure Information

 

References

Intralesional steroid injections with triamcinolone 10 mg/mL can reduce local pain and inflammation rapidly. Pain management is also critical, as HS is painful. First-line therapy includes nonsteroidal anti-inflammatory drugs, acetaminophen, atypical anticonvulsants, and serotonin and norepinephrine reuptake inhibitors.2 Opiate analgesics may be needed for breakthrough pain in patients with severe disease. Avoiding tight clothing, harsh products, and adhesive dressings, as well as using clear petroleum jelly, can prevent skin trauma and help with healing. Weight loss and smoking cessation are also associated with better outcomes.6,7

If medical management fails …

If there is no improvement with medical management, it may be time to consider local procedures such as unroofing/deroofing, punch debridement, skin-tissue-sparing excision with electrosurgical peeling, and laser excision. Incision and drainage may be necessary for acutely inflamed, painful abscesses but should not be routinely performed because lesions can recur.3

Referral to a plastic surgeon is necessary when patients are considering wide excisions of largely affected areas. Even when surgical excisions are performed, medical treatment is needed to prevent new lesions and recurrences.

Our patient was treated initially with oral doxycycline 100 mg bid and intralesional triamcinolone (10 mg/mL) in the most tender lesions. He was also provided with a prescription for ibuprofen 800 mg tid to be taken with meals. The family physician encouraged the patient to lose weight. The patient derived some benefit from treatment but continued to experience new painful lesions.

Hidradenitis suppurativa is painful, and thus, pain management is critical.

The physician prescribed oral clindamycin 300 mg bid at a follow-up visit to replace the oral doxycycline. When this failed, the patient was sent for labs to determine if he would be a candidate for adalimumab. When the screening labs were normal, a prescription for adalimumab was provided: 160 mg subcutaneously at Week 0, 80 mg at Week 2, and then 40 mg weekly.4

Pages

Recommended Reading

Explaining Away Those Shades of Gray
Clinician Reviews
Atopic dermatitis subtype worsens into midlife, predicting poor health
Clinician Reviews
New guidance on preventing cutaneous SCC in solid organ transplant patients
Clinician Reviews
Novel diabetic foot ulcer cream shows promise in phase 3 trial
Clinician Reviews
Urticaria and edema in a 2-year-old boy
Clinician Reviews
FDA approves topical ruxolitinib for atopic dermatitis, first JAK inhibitor for this indication in the U.S.
Clinician Reviews
New virus causing ‘Alaskapox’ detected in two more cases
Clinician Reviews
Oteseconazole promising for recurrent yeast infections
Clinician Reviews
Nonsteroidal topical found effective for psoriasis in 52-week study
Clinician Reviews
Facing Up to the Diagnosis
Clinician Reviews